CINCINNATI--(BUSINESS WIRE)--Oct. 17, 2016--
Medpace Holdings Inc. (“Medpace”) today announced that it will report
its third quarter 2016 financial results after the market close on
Thursday, November 3, 2016, and will host a conference call the
following morning, Friday, November 4, 2016, at 9:00 a.m. ET to discuss
To participate in the conference call, dial 800-219-7113 (domestic) or
574-990-1030 (international) using the passcode 2112859.
To access the conference call via webcast, visit the “Investors” section
of Medpace’s website at www.investor.medpace.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A supplemental slide presentation will also be available at the
“Investors” section of Medpace’s website prior to the start of the call.
A recording of the call will be available from 12:00 p.m. ET on Friday,
November 4, 2016 until 11:00 a.m. ET on Friday, November 18, 2016. To
hear this recording, dial 855-859-2056 (domestic) or 404-537-3406
(international) using the passcode 2112859.
Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical and medical
device industries. Medpace’s mission is to accelerate the global
development of safe and effective medical therapeutics through its
physician-led, high-science, and disciplined operating approach that
leverages regulatory and therapeutic expertise across all major areas
including oncology, cardiology, metabolic disease, endocrinology,
central nervous system and anti-viral and anti-infective. Headquartered
in Cincinnati, Ohio, Medpace employs approximately 2,300 people across
View source version on businesswire.com: http://www.businesswire.com/news/home/20161017006386/en/
Source: Medpace Holdings Inc.
Medpace Holdings, Inc.
Mary Kuramoto, 513-579-9911 x2523